Abdulkader Alam1, Zoya Voronovich1, Joseph A Carley1. 1. Departments of Psychiatry and Medicine (Dr Alam), University of Pittsburgh School of Medicine (Ms Voronovich), Pittsburgh, Pennsylvania; and University of Alabama School of Medicine, Birmingham (Dr Carley).
Abstract
OBJECTIVE: To review the literature examining the use of mirtazapine with an emphasis on its therapeutic benefits for psychiatric patients with comorbid medical conditions. DATA SOURCES: MEDLINE, PsycINFO, Global Health, and AGRICOLA were searched using the terms mirtazapine OR Remeron. Limits were English language, human, year 1980-2012, treatment and prevention, and therapy. STUDY SELECTION: Two hundred ninety-three articles were identified. DATA EXTRACTION: Identified articles were reviewed with a focus on indications and therapeutic benefits in patients with medical comorbidities. RESULTS: Mirtazapine is an effective antidepressant with unique mechanisms of action. It is characterized by a relatively rapid onset of action, high response and remission rates, a favorable side-effect profile, and several unique therapeutic benefits over other antidepressants. Mirtazapine has also shown promise in treating some medical disorders, including neurologic conditions, and ameliorating some of the associated debilitating symptoms of weight loss, insomnia, and postoperative nausea and vomiting. CONCLUSIONS: Mirtazapine offers clinicians multiple therapeutic advantages especially when treating patients with comorbid medical illness.
OBJECTIVE: To review the literature examining the use of mirtazapine with an emphasis on its therapeutic benefits for psychiatricpatients with comorbid medical conditions. DATA SOURCES: MEDLINE, PsycINFO, Global Health, and AGRICOLA were searched using the terms mirtazapine OR Remeron. Limits were English language, human, year 1980-2012, treatment and prevention, and therapy. STUDY SELECTION: Two hundred ninety-three articles were identified. DATA EXTRACTION: Identified articles were reviewed with a focus on indications and therapeutic benefits in patients with medical comorbidities. RESULTS:Mirtazapine is an effective antidepressant with unique mechanisms of action. It is characterized by a relatively rapid onset of action, high response and remission rates, a favorable side-effect profile, and several unique therapeutic benefits over other antidepressants. Mirtazapine has also shown promise in treating some medical disorders, including neurologic conditions, and ameliorating some of the associated debilitating symptoms of weight loss, insomnia, and postoperative nausea and vomiting. CONCLUSIONS:Mirtazapine offers clinicians multiple therapeutic advantages especially when treating patients with comorbid medical illness.
Authors: John Liappas; Thomas Paparrigopoulos; Elias Tzavellas; Andreas Rabavilas Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2004-11-23 Impact factor: 5.067
Authors: Jerónimo Saiz-Ruiz; Jose Manuel Montes; Angela Ibáñez; Marina Díaz; Francisco Vicente; Carmelo Pelegrín; Rosa Viñas; Francisco Arias; Jose Luis Carrasco; Laura Ferrando Journal: Hum Psychopharmacol Date: 2005-08 Impact factor: 1.672
Authors: Davide Uccellini; G Grampa; I La Spina; D Nasuelli; I Neromante; L Politini; F Reverberi; D Porazzi; V Carli; G Camardese Journal: Neuropsychiatr Dis Treat Date: 2006-03 Impact factor: 2.570
Authors: Peter de Jonge; Adriaan Honig; Joost P van Melle; Aart H Schene; Astrid M G Kuyper; Dorien Tulner; Annique Schins; Johan Ormel Journal: Am J Psychiatry Date: 2007-09 Impact factor: 18.112
Authors: O J Høyberg; B Maragakis; J Mullin; D Norum; E Stordall; P Ekdahl; E Ose; K M Moksnes; C Sennef Journal: Acta Psychiatr Scand Date: 1996-03 Impact factor: 6.392
Authors: Abdel-Aziz Shaheen; Gilaad G Kaplan; Wagdi Almishri; Isabelle Vallerand; Alexandra D Frolkis; Scott Patten; Mark G Swain Journal: PLoS One Date: 2018-04-04 Impact factor: 3.240